← Evidence map

ArticleJournal of translational medicine2023

EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma.

Yujie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

25 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36647156